P0C024 (NUDT7_HUMAN) Homo sapiens (Human)

Peroxisomal coenzyme A diphosphatase NUDT7 UniProtKBInterProSTRINGInteractive Modelling

238 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

38 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of Human Peroxisomal coenzyme A diphosphatase NUDT7homo-3-mer13-233
10010×EDO;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H5D;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H0D;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H0P;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;H3D;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H31;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H3A;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H2J;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H1J;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H4G;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H5G;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H1G;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H47;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H3G;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H1Y;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;GZY;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H0G;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H54;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H1P;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;H0A;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H0S;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H2D;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46H4A;ACT;DMS;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H3V;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H2G;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H17;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H2Y;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;B0V;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H3J;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H4D;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H1A;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H4Y;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H0J;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H04;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H0M;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H3Y;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H2M;
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomer14-209
99.46ACT;DMS;H5A;

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5t3p.1.Ahomo-3-mer0.8913-233
100.00
6glk.1.Amonomer0.5439-198
17.01

2 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25t3p.1.Ahomo-3-mer0.8113-180
100.00
Isoform 35t3p.1.Ahomo-3-mer0.8113-124
94.31